STAT42%
Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer 69%
By Brittany Trang82%
7/20/2026, 10:59:00 AM
BS Summary: This article contains 20 faulty reasoning types, including Post Hoc (False Cause), Confirmation Bias, and Attempt to Sell a Product or Service, with Appeal to Authority as the most egregious example at 49.7% saturation with 80 hits. Analysis detected 707 faulty-reasoning hits from 161 analyzed words, generating a BS Score of 62.3% and a BS Rank of 69% (6,572 of 20,882 articles). This article is worse (more manipulative) than 68.50% of the article peer group.
It’s officially a trend.
For the third time in nine months, a pharma company has announced that it is assembling the largest AI supercomputer in the life sciences industry.
This time, it is Bristol Myers Squibb.
When the company began its partnership with NVIDIA three years ago with a smaller computing cluster, it was focusing on simpler problems with individual AI tools, like protein structure prediction.
But “we actually consumed all the space we had,” said Greg Meyers, chief digital & technology officer at BMS.
Adding extra computing power is necessary for the company now that it’s “become more convinced” that computationally hungry foundation models can give the company valuable insight into how its drug candidates interact with both the body and with disease, Meyers said in an interview with STAT.
He mentioned oncology and neurodegeneration as examples of areas where BMS has developed such models.
Speakers
1speaker50%attributed speech81writer words
Voice mapSelect a segment to jump to its words
Selected voice
100%flagged-word coverageGreg Meyers
80 attributed words100% of attributed speech100% writer coverage
Attribution is sentence-level. Pattern percentages are calculated only from words assigned to that voice.
Loading…
Loading…
Loading…
Analysis
Hover over highlighted words in the article to view the associated bias or fallacy analysis.